10-Nitrooleate-d17
(Synonyms: 10Nitrooleic Acidd17, 10nitro9-trans-Octadecenoic Acidd17) 目录号 : GC46403A neuropeptide with diverse biological activities
Cas No.:2749984-40-3
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
10-
1.Lim, D.G., Sweeney, S., Bloodsworth, A., et al.Nitrolinoleate, a nitric oxide-derived mediator of cell function: Synthesis, characterization, and vasomotor activityProceedings of the National Academy of Sciences of the United States of America99(25)15941-15946(2002) 2.Schopfer, F.J., Lin, Y., Baker, P.R.S., et al.Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor g ligandProceedings of the National Academy of Sciences of the United States of America102(7)2340-2345(2005) 3.Lima, E.S., Bonini, M.G., Augusto, O., et al.Nitrated lipids decompose to nitric oxide and lipid radicals and cause vasorelaxationFree Radical Biology & Medicine39532-539(2005) 4.Baker, P.R.S., Schopfer, F.J., Sweeney, S., et al.Red cell membrane and plasma linoleic acid nitration products: Synthesis, clinical identification, and quantitationProceedings of the National Academy of Sciences of the United States of America101(32)11577-11582(2004) 5.Baker, P.R., Lin, Y., Schopfer, F.J., et al.Fatty acid transduction of nitric oxide signaling. Multiple nitrated unsaturated acid derivatives exist in human blood and urine serve as endogenous peroxisome proliferator-activated receptor ligandsThe Journal of Biological Chemisty280(51)42464-42475(2005)
Cas No. | 2749984-40-3 | SDF | |
别名 | 10Nitrooleic Acidd17, 10nitro9-trans-Octadecenoic Acidd17 | ||
Canonical SMILES | [2H]C(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])([2H])/C([N+]([O-])=O)=C\CCCCCCCC(O)=O | ||
分子式 | C18H16D17NO4 | 分子量 | 344.6 |
溶解度 | Ethanol: 1 mg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.9019 mL | 14.5096 mL | 29.0192 mL |
5 mM | 0.5804 mL | 2.9019 mL | 5.8038 mL |
10 mM | 0.2902 mL | 1.451 mL | 2.9019 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。